Market Overview

The Bicalutamide market is predicted to develop at a compound annual growth rate (CAGR) of 8.11% from 2024 to 2034, when it is projected to reach USD 4.52 Billion, based on an average growth pattern. The market is estimated to reach a value of USD 1.92 Billion in 2024.

SOURCE: We Market Research

Belicutamide is a medication used to treat prostate cancer by blocking the function of male hormones like testosterone, which can promote the growth of cancer cells. The oral medication bicalutamide is often used in combination with other treatments, such as hormone therapy or surgery, for the treatment of prostate cancer. It functions as an anti-androgen, inhibiting the harmful effects of testosterone on cancerous cells. Off-label uses of belicutamide include regulating women's excessive hair growth. Beclomethasone must be taken exactly as directed by a healthcare provider due to potential side effects and drug interactions.

A number of factors are driving the bicalutamide market worldwide. The global rise in prostate cancer cases and the progress made in cancer therapies fuel the market for this drug. Prostate cancer incidence rises with age, which increases the need for efficient treatments like bicalutamide. Proactive screening programs and increased awareness help with early detection and treatment initiation, which drives market expansion. The market reach is increased by improved healthcare access in emerging nations. Innovation is propelled by ongoing research and development initiatives targeted at improving the safety and efficacy profiles of bicalutamide. Market expansion is also greatly aided by favorable reimbursement and regulatory approval policies. 

Market Scope

Bicalutamide Industry: Dynamics & Restrains

We Market Research: Bicalutamide Dashboard

Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.

Bicalutamide Segmentation

Market- By Type Analysis

By Type, the Bicalutamide Market is Categories into Tablets, Injectable Formulations, Capsule. The Tablets segment accounts for the largest share of around 57% in 2024.

Tablets dominate the bicalutamide market due to its price, ease of manufacturing, precision in dosage monitoring, patient preference for oral administration, and convenience. These factors contribute to its widespread adoption by healthcare providers and patients undergoing prostate cancer treatment regimens.

The following segments are part of an in-depth analysis of the global Bicalutamide market:

Bicalutamide Industry: Regional Analysis

North America Market Forecast

North America dominate the Bicalutamide Market with the highest revenue generating market with share of more than 48%. North America leads the world in bicalutamide sales because to its robust healthcare system and high prostate cancer incidence. Prostate cancer screening being more well known, innovative treatment options, and favorable reimbursement policies are some of the driving forces behind the market's growth.

Europe Market Statistics

Europe is second largest region in Bicalutamide Market. Europe also accounts for a sizable portion of the bicalutamide market. A sizable patient base, an aging population, and continuous research and development efforts are the main factors driving the industry. The rise of the industry is facilitated by government initiatives that raise awareness of cancer and provide accessibility to healthcare.

Asia Pacific Market Forecasts

Asia Pacific is expected to be the fastest-growing regional segment of the Bicalutamide market during the forecast period. In the Asia Pacific region, growing healthcare spending, a rise in prostate cancer cases, and bettering healthcare infrastructure are driving this region's bicalutamide market's explosive expansion. China and India, two emerging economies, are major drivers of market expansion.

Key Market Players

The Bicalutamide Market is dominated by a few large companies, such as

·         AstraZeneca

·         CORDEN PHARMA GMBH

·         Zeneca GmbH

·         Actavis Pharma

·         Sivem Pharmaceuticals

·         Sorres Pharma

·         Fresenius Kabi

·         ANI Pharmaceuticals

·         Accel Pharma

·         Other

1.      Global Bicalutamide Market Introduction and Market Overview

1.1.    Objectives of the Study

1.2.    Global Bicalutamide Market Scope and Market Estimation

1.2.1. Global Bicalutamide Overall Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2034)

1.2.2. Global Bicalutamide Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2034

1.3.    Market Segmentation

1.3.1. Component of Global Bicalutamide Market

1.3.2. Technology of Global Bicalutamide Market

1.3.3. Distribution Channel of Global Bicalutamide Market

1.3.4. Region of Global Bicalutamide Market

2.      Executive Summary

2.1.    Global Bicalutamide Market Industry Trends under COVID-19 Outbreak

2.1.1. Global COVID-19 Status Overview

2.1.2. Influence of COVID-19 Outbreak on Global Bicalutamide Market Industry Development

2.2.    Market Dynamics

2.2.1. Drivers

2.2.2. Limitations

2.2.3. Opportunities

2.2.4. Impact Analysis of Drivers and Restraints

2.3.    Pricing Trends Analysis & Average Selling Prices (ASPs)

2.4.    Key Mergers & Acquisitions, Expansions, JVs, Funding / VCs, etc.

2.5.    Porter’s Five Forces Analysis

2.5.1. Bargaining Power of Suppliers

2.5.2. Bargaining Power of Buyers

2.5.3. Threat of Substitutes

2.5.4. Threat of New Entrants

2.5.5. Competitive Rivalry

2.6.    Value Chain / Ecosystem Analysis

2.7.    Russia-Ukraine War Impacts Analysis

2.8.    Economic Downturn Analysis

2.9.      Market Investment Opportunity Analysis (Top Investment Pockets), By Segments & By Region

3.      Global Bicalutamide Market Estimates & Historical Trend Analysis (2019 - 2023)

4.      Global Bicalutamide Market Estimates & Forecast Trend Analysis, by TYPE

4.1.    Global Bicalutamide Market Revenue (US$ Mn) Estimates and Forecasts, by TYPE, 2019 to 2034

4.1.1. Tablets

4.1.2. Injectable Formulations

4.1.3. Capsule

5.      Global Bicalutamide Market Estimates & Forecast Trend Analysis, by Application

5.1.    Global Bicalutamide Market Revenue (US$ Mn) Estimates and Forecasts, by Application, 2019 to 2034

5.1.1. Single Drug for Prostate Cancer

5.1.2. Combined Chemotherapy for Prostate Cancer

6.      Global Bicalutamide Market Estimates & Forecast Trend Analysis, by Distribution Channel

6.1.    Global Bicalutamide Market Revenue (US$ Mn) Estimates and Forecasts, by Distribution Channel, 2019 to 2034

6.1.1. Hospital Pharmacies

6.1.2. Retail Pharmacies

6.1.3. Online Pharmacies

7.      Global Bicalutamide Market Estimates & Forecast Trend Analysis, by END USER

7.1.    Global Bicalutamide Market Revenue (US$ Mn) Estimates and Forecasts, by Distribution Channel, 2019 to 2034

7.1.1. Hospitals & Clinics

7.1.2. Ambulatory Surgical Centers

7.1.3. Specialty Clinics

8.      Global Bicalutamide Market Estimates & Forecast Trend Analysis, by Region

8.1.    Global Bicalutamide Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019 to 2034

8.1.1. North America

8.1.2. Europe

8.1.3. Asia Pacific

8.1.4. Middle East & Africa

8.1.5. South America

9.      North America Bicalutamide Market: Estimates & Forecast Trend Analysis

9.1.    North America Bicalutamide Market Assessments & Key Findings

9.1.1. North America Bicalutamide Market Introduction

9.1.2. North America Bicalutamide Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

9.1.2.1.   By TYPE

9.1.2.2.   By Application

9.1.2.3.   By Distribution Channel

9.1.2.4.   By END USER

9.1.2.5.   By Country

9.1.2.5.1.     The U.S.

9.1.2.5.2.     Canada

9.1.2.5.3.     Mexico

10.  Europe Bicalutamide Market: Estimates & Forecast Trend Analysis

10.1.  Europe Bicalutamide Market Assessments & Key Findings

10.1.1.   Europe Bicalutamide Market Introduction

10.1.2.   Europe Bicalutamide Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

10.1.2.1.    By TYPE

10.1.2.2.    By Application

10.1.2.3.    By Distribution Channel

10.1.2.4.    By END USER

10.1.2.5.    By Country

10.1.2.5.1. Germany

10.1.2.5.2. U.K.

10.1.2.5.3. France

10.1.2.5.4. Italy

10.1.2.5.5. Spain

10.1.2.5.6. Russia

10.1.2.5.7. Rest of Europe

11.  Asia Pacific Bicalutamide Market: Estimates & Forecast Trend Analysis

11.1.  Asia Pacific Market Assessments & Key Findings

11.1.1.   Asia Pacific Bicalutamide Market Introduction

11.1.2.   Asia Pacific Bicalutamide Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

11.1.2.1.    By TYPE

11.1.2.2.    By Application

11.1.2.3.    By Distribution Channel

11.1.2.4.    By END USER

11.1.2.5.    By Country

11.1.2.5.1. China

11.1.2.5.2. Japan

11.1.2.5.3. India

11.1.2.5.4. Australia

11.1.2.5.5. South Korea

11.1.2.5.6. ASEAN

11.1.2.5.7. Rest of Asia Pacific

12.  Middle East & Africa Bicalutamide Market: Estimates & Forecast Trend Analysis

12.1.  Middle East & Africa Market Assessments & Key Findings

12.1.1.   Middle East & Africa Bicalutamide Market Introduction

12.1.2.   Middle East & Africa Bicalutamide Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

12.1.2.1.    By TYPE

12.1.2.2.    By Application

12.1.2.3.    By Distribution Channel

12.1.2.4.    By END USER

12.1.2.5.    By Country

12.1.2.5.1. U.A.E.

12.1.2.5.2. Saudi Arabia

12.1.2.5.3. Egypt

12.1.2.5.4. South Africa

12.1.2.5.5. Rest of Middle East & Africa

13.  South America Bicalutamide Market: Estimates & Forecast Trend Analysis

13.1.  South America Market Assessments & Key Findings

13.1.1.   South America Bicalutamide Market Introduction

13.1.2.   South America Bicalutamide Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

13.1.2.1.    By TYPE

13.1.2.2.    By Application

13.1.2.3.    By Distribution Channel

13.1.2.4.    By END USER

13.1.2.5.    By Country

13.1.2.5.1. Brazil

13.1.2.5.2. Argentina

13.1.2.5.3. Colombia

13.1.2.5.4. Rest of South America

14.  Competition Landscape

14.1.  Global Bicalutamide Market Competition Matrix & Benchmarking, by Leading Players / Innovators / Emerging Players / New Entrants

14.2.  Global Bicalutamide Market Competition White Space Analysis, By Distribution Channel

14.3.  Global Bicalutamide Market Competition Heat Map Analysis, By Distribution Channel

14.4.  Global Bicalutamide Market Concentration & Company Market Shares (%) Analysis, 2022

15.  Company Profiles

15.1.                     AstraZeneca

15.1.1.   Company Overview & Key Stats

15.1.2.   Financial Performance & KPIs

15.1.3.   Product Portfolio

15.1.4.   Business Strategy & Recent Developments

* Similar details would be provided for all the players mentioned below 

15.2.      CORDEN PHARMA GMBH

15.3.      Zeneca GmbH

15.4.      Actavis Pharma

15.5.      Sivem Pharmaceuticals

15.6.      Sorres Pharma

15.7.      Fresenius Kabi

15.8.      ANI Pharmaceuticals

15.9.      Accel Pharma

15.10.  Others

16.  Research Methodology

16.1.  External Transportations / Databases

16.2.  Internal Proprietary Database

16.3.  Primary Research

16.4.  Secondary Research

16.5.  Assumptions

16.6.  Limitations

16.7.  Report FAQs

17.  Research Findings & Conclusion